A family history of colorectal cancer is known to increase personal risk of disease in a variety of study settings. [1] [2] [3] [4] [5] [6] This 2-3-fold increase in risk is observed in both men and women, although few studies have focused exclusively on the association between family history and colorectal cancer incidence in women. 5, 6 There is now considerable evidence that hormones influence risk of colorectal cancer in women. 7, 8 Most compelling is the approximately halving of risk for current users of hormone replacement therapy. It is of interest therefore, whether the association of hormones differs for women with a family history of the disease, compared to women without such a family history.
diagnosis were potentially eligible for this study. These potential case subjects with incident cases of large bowel cancer were enrolled concurrently with case subjects who had breast cancer for a larger study of cancer in women, identified by Wisconsin's statewide cancer-reporting system, and were reported to the registry in 1990 and 1991. 9 Information was available on cancer site, histology, extent of disease, date of birth, race and follow-up physician. The information in the registry is about 97% complete. According to an institutionally approved protocol, the physician listed on the record for each eligible case was contacted by mail to obtain permission to approach the potential case subject.
Eligibility was further limited to case subjects with drivers' licences (if Ͻ65 years old) and listed telephone numbers. Of the 1061 identified case subjects, physicians refused contact for 108 of their patients, 40 patients refused to participate, 2 could not be located, 185 had died, and 726 women completed the interview. It was not possible to evaluate the eligibility status of deceased subjects; however, on the basis of loss attributable to lack of a telephone number or drivers' licence or other information for all case subjects, we estimated the overall response rate to be 74% (or 84% of living eligible case subjects.) This case group (n = 726) included 502 women with a diagnosis of colon cancer and 224 women with a diagnosis of rectal cancer. Of these, 98% had histological confirmation of invasive large bowel cancer.
Identification of control subjects
Community control subjects were randomly selected from two sampling frames. Control subjects younger than 65 years were selected from a list of licensed female drivers in Wisconsin. Control subjects aged 65-74 years were selected from a roster of female Medicare beneficiaries compiled by the Health Care Financing Administration, Baltimore, MD. 10 The control subjects were selected to have an age distribution similar to that of the breast cancer case subjects in the ongoing parallel study, but the selection was otherwise made at random. Control subjects had to have a listed telephone number and no previous diagnosis of large bowel cancer. Of the 2566 eligible control subjects, 32 had died, 197 refused to participate in the study, and 22 could not be located. The overall response rate was 90% (or 92% of living eligible control subjects), yielding 2315 control subjects.
Data collection
Case and control subjects were sent letters briefly describing the study before they were contacted by telephone. The 25-minute telephone interview elicited information on known or suspected risk factors for large bowel cancer, including family history of colorectal cancer. History of colon or rectal cancer in mother, father and siblings was ascertained. Age at diagnosis of the relative was not collected, nor was family size. The interview also covered reproductive experiences, early life physical activity, age-specific alcohol history, selected dietary elements, height and weight, smoking status, medical history, and demographic factors. Information about the women's personal histories and family histories of large bowel cancer was obtained at the end of the interview to maintain blinding. Participants also completed a self-administered food frequency questionnaire. 11 Information regarding family history was missing for 24 cases (3.3%) and 41 ( 
Data analysis
Only exposure status prior to an assigned reference date was used in the analysis. For case subjects, this exposure status was the date of colorectal cancer diagnosis. For comparability, control subjects were assigned a reference date that corresponded to the average time from diagnosis to interview for the case group, i.e. about one year.
Age was defined as the age at diagnosis for case subjects or age at reference date for control subjects. Menopausal status was defined as 'postmenopausal' if the subject reported a natural menopause or a bilateral oophorectomy prior to the diagnosis or to the reference date. Women were classified as having a positive family history if they reported their mother, father or sibling as diagnosed with colon or rectal cancer.
Odds ratios and 95% confidence intervals (CI) obtained from logistic regression models were used to estimate relative risks (RR). Conditional models were used to account for the different age distributions of the case and control subjects. As tests for trend, we used regression models to fit categorical variables. Effect modification was considered by including interaction terms in the model and evaluating the significance of likelihood ratio tests. 12 Subjects with unknown values for any variables in the multivariate model were included as a separate category (as for BMI and history of screening sigmoidoscopy).
We evaluated a number of factors that might confound the relationship between family history and incidence of colorectal cancer. Case subjects tended to be older than control subjects, who had been selected to match the age distribution of a breast cancer case group. After age adjustment, case subjects tended to be heavier, 13 less likely to take postmenopausal hormone replacement therapy, 14 and more likely to have consumed high levels of alcohol 15 or tobacco. 16 All results are adjusted for these factors. Neither early life (ages 14-22 years) physical activity nor dietary factors, specifically folate intake, were confounders in these data.
Results
Large bowel cancer in a mother, father or sibling was reported by 18.1% of cases and 9.9% of controls (Table 1) . Nineteen cases (2.7%) and 20 controls (0.9%) reported more than one relative with colorectal cancer. Cases were less likely than controls to report a history of screening sigmoidoscopy (prior to diagnosis) or to have used hormone replacement therapy.
Compared to women without a family history of the disease, the multivariate-adjusted RR of colorectal cancer for women with a family history was 2.07 (95% CI : 1.60-2.68) ( Table 2) . Risks appeared to be slightly higher for colorectal cancer history in a parent than for a sibling, but were similar whether the affected relative was a mother or a father. Further, risks were very significantly elevated among women with two or more affected relatives (RR 3.65, 95% CI : 1.81-7.37). These multivariate adjusted RR differed only slightly from estimates c Postmenopausal women only; Controls = 1547; Cases: colorectal = 617, colon = 431, rectal = 186. obtained after adjustment only for age, suggesting that confounding was unlikely to have introduced substantial bias. Family history of colorectal cancer appeared to be more strongly associated with colon rather than rectal cancer risk ( Table 2 ). The RR for colon cancer (RR 2.27, 95% CI : 1.70-3.04) was slightly greater than the risk for rectal cancer (RR 1.65, 95% CI : 1.09-2.51). There was also a suggestion that family history was more strongly associated with proximal rather than distal lesions, although small case numbers limited this evaluation. Again, adjustment for other risk factors did not alter these associations.
We examined the risk associated with family history of colorectal cancer and whether it varied according to other personal characteristics and to hormone factors (Table 3 ). There were no consistent patterns associated with age at diagnosis and family history. The greatest RR were observed in women at younger (Ͻ55 years) ages compared to women aged 60-69. There was some evidence that higher parity modified the risk associated with a positive family history. The RR for colorectal cancer decreased with high parity for women with a family history (P = 0.07); the RR for nulliparous women with a family history was 2.38 (95% CI : 1.38-4.09), yet for higher parity (>4) the RR Use of oral contraceptives did not modify the association between family history and colorectal cancer (P-interaction 0.76). Women with a family history who also took oestrogen replacement therapy had an RR of 2.56 (95% CI : 1.56-4.21), which was not significantly different from the multivariate adjusted RR of colorectal cancer for women with a family history who did not use hormones. Although sample sizes were small, the RR for colon cancer increased with age at menopause for women with a family history of colon cancer compared to women without such a history (P-interaction 0.03).
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We considered stage of disease and screening history as possible indicators of increased detection among women with a family history of colorectal cancer. Women with a family history of colorectal cancer were as likely as women with a negative history to have their tumours detected at local stages (39% and 38%, respectively). History of sigmoidoscopic screening was similarly reported by women with and without a family history of colorectal cancer. Thus, it seems unlikely that increased surveillance accounts for the elevated risk of colorectal cancer among those with a family history.
Discussion
Overall, in this large study of women, family history of colorectal cancer was associated with a twofold risk of the same malignancy. This risk was greater among subgroups of women with history in either parent than for a sibling. There was no indication that hormonal exposures consistently modified this risk. However, risk for colon cancer appeared attenuated among women with a family history and higher parity, and greater among women with a family history of colorectal cancer who reached menopause at younger ages, but the sample sizes were quite small.
The results of this study are generally consistent with previous reports of the relation between family history and risk of colorectal cancer. [1] [2] [3] [4] [5] [6] However, studies have been inconsistent on a risk differential according to site. As proposed by McMichael, distal lesions are more likely to represent environmental exposures. 17 While we observed this association, as have others, 3, 4, 18, 19 several studies have not observed sitespecific differences, including the Nurse's Health Study. 5 In addition, Slattery et al. found greater risk for tumours in the distal colon. 20 However, in all these studies the number of right-sided tumours seriously limited the statistical power to detect differences. In colorectal cancer studies, the risk associated with a family history appears, quite consistently, to be slightly attenuated in the rectum compared to the colon.
No significant interactions between exogenous hormonal risk factors and family history emerged in these data, although there was some indication that high parity and early menopause may moderate the risks associated with family history. There is now a substantial body of data to support an inverse relationship associated with the use of postmenopausal oestrogen and large bowel cancer risk. 7, 8, 14 The reduction in risk may be as great as 50% among women who recently used hormone replacement therapy (HRT). 14 Despite the strength of this association, we did not observe any effect modification of family history by HRT.
Other characteristics of large bowel epidemiology also suggest a role for endocrine factors, including parity, oral contraceptives, and age at menarche. 21, 22 It is perhaps notable that these potential interactions reflect early life exposures, rather than the relatively recent experiences with HRT. Other reports of family history and colorectal cancer have not reported on these hormonal interactions.
Recall of family history differentially between cases and controls could lead to an overestimation of our measure of family association that increases with increasing numbers of relatives. 23 In general, however, family history of colon cancer appears to be reported with high sensitivity and specificity. [24] [25] [26] These studies found that women report more accurately than men. We also found, in a re-interview study of 211 controls participating in the parent study, that family history of cancer was recalled with a high degree of reliability (Pearson correlation between family history of cancer reported in the two interviews as r = 0.86). 27 It is reassuring that the results of our study are nearly identical to those of a large prospective evaluation. 5 Although the high participation rates of the controls (90%) reduces concerns about selection bias, there was some loss to death in the case group. If family history is associated with colorectal cancer mortality, our risk estimates may have been attenuated. Surveillance bias is unlikely to explain our observed associations since the stage of disease was similar among women with a family history. Although sigmoidoscopy screening levels did differ slightly, we were able to take these into account in our analyses. Limiting our cases and controls only to those women with a sigmoidoscopy history yielded similar RR.
Self-reported family history of colorectal cancer was necessarily used as a proxy for susceptibility of truly inherited disease, and probably included known genetic syndromes such as hereditary non-polyposis colorectal cancer (HNPCC), familial adenomatous polyposis (FAP), family aggregation with as yet undefined genetic basis, as well as truly sporadic cases. 28 Because some proportion of family disease occurs by chance or shared environmental exposure, we may have overestimated the prevalence of true familial disease. 29 Other designs, such as those incorporating relative controls, would permit the isolation of true inherited genetic susceptibility. Further, although we controlled for some risk factors that may cluster in families, other unknown or unmeasured factors may account for some of the observed associations. In other studies, adjustment for other known or suspected risk factors for colon cancer did not change the risk associated with a positive family history, 5, 6 suggesting genetic aspects of non-syndromic colorectal cancer. Despite the classification difficulties inherent in this and other populationbased familial studies, most indicate similar risks associated with genetic susceptibility, as defined by family history reports. Of course, for those families with highly penetrant syndromes, the RR are considerably higher. 30 In summary, in this population-based study of women, selfreported family history of colorectal cancer was associated with a doubling of risk of large bowel cancer that did not appear to be modified by measures of hormone exposure. Yet, while the RR are similar, the strong inverse association between HRT and colorectal cancer risk suggests that, in absolute terms, the benefits of hormone therapy are even more important for women with a family history of large bowel cancer than for those without a family history. IN WOMEN 607 
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